Severe Post-COVID-19 Organizing Pneumonia during Cancer Immunochemotherapy

A 44-year-old man developed coronavirus disease 2019 (COVID-19) pneumonia during immunochemotherapy consisting of carboplatin, paclitaxel, and pembrolizumab for non-small cell lung cancer. Low-grade fever, followed by mild hypoxemia, and febrile neutropenia, were observed, and granulocyte colony-sti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitahara, Asako, Ebihara, Akinori, Obayashi, Shohei, Horio, Yukihiro, Ono, Yoshitaka, Yoshikawa, Tomohiro, Okada, Naoki, Tanaka, Jun, Takiguchi, Hiroto, Hayama, Naoki, Ito, Yoko, Oguma, Tsuyoshi, Kuwahira, Ichiro, Asano, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107986/
https://www.ncbi.nlm.nih.gov/pubmed/35135922
http://dx.doi.org/10.2169/internalmedicine.8928-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107986/
https://www.ncbi.nlm.nih.gov/pubmed/35135922
http://dx.doi.org/10.2169/internalmedicine.8928-21

Ejemplares similares